2021 annual shareholder meeting
rapat umum pemegang saham 2021 |
|
 |
|
 |
 |
|
Suasana saat rapat,
banyak peserta yang hadir secara virtual karena
masih dalam suasana pandemi
The atmosphere during meeting, many
participants attended virtually because we are
currently still in a pandemic. |
|
 |
Peresmian Ruang Meeting "J.E. Sendjaja", sebagai penghormatan kepada almarhum
J.E. Sendjaja, salah satu founder MJB.
Inauguration of "J.E. Sendjaja" Meeting Room, as a tribute to the late
J.E. Sendjaja, one of the founders of MJB. |
|
Peresmian ruang produksi Ampoule berteknologi Jerman,
oleh para shareholders yang hadir dalam rapat.
The inauguration of the Ampoule production room with German technology,
by the shareholders who were present at the meeting. |
 |
|
|
awards for best performances |
|
 |
 |
|
 |
Para peraih penghargaan untuk performa
terbaik
di bidang sales dan di kantor.
Award winners for top performance in sales
and in the office. |
|
Pimpinan MJB bersama para peraih penghargaan di bidang sales dari Aceh,
Jabar, Jateng dan NTT, yang diundang khusus karena performa terbaik mereka.
MJB leaders along with award winners in the field of sales from Aceh,
West Java, Central Java and NTT, who were specially invited for their best performance. |
 |
|
|
 |
Produk MJB Pharma yang sudah ada dan yang akan dilaunching.
Existing and upcoming MJB Pharma products. |
|
|
2020 achievements |
|
 |
Sales domestik meningkat 7% plus toll 29%.
Achievements in 2020: domestic sales increase 7% plus toll 29%. |
|
 |
Dengan menunda IPO bisa mulai private placement.
Achievements in 2020: By delaying the IPO, we can start a private placement. |
|
 |
|
Sales dan Marketing serius memasuki red ocean dengan team baru,
plus launching Cetasering (yang kemudian diganti nama "Acetar"
dan telah dilaunching pada bulan September 2020)
berikut Gen3B (yang peluncurannya masih tertunda).
Sales and Marketing seriously entered Red Ocean with a new team,
plus the launch of Cetasering (which was later renamed "acetar"
and was launched in September 2020) and Gen3B (whose launch is still pending). |
|
|
2021 programs |
|
 |
Pada tahun 2020, pertumbuhan rata-rata dari perusahaan farmasi adalah 2-4%
(dilansir oleh Moody's Investors Service). Sementara MJB meningkat sebanyak 29%.
In 2020, the average growth of pharmaceutical companies is 2-4%
(as reported by Moody's Investors Service). Meanwhile MJB increased by 29%. |
|
 |
 |
|
 |
 |
|
Core Business : Infus
Basic Solution: meningkatkan penyebaran
RO.
Acetar : sudah dilaunching pada bulan
Oktober 2020.
Ampoule : sedang menunggu Nomor Ijin Edar
(NIE).
|
Core Business: Infusion
-
Export & Toll: increase area and
production
-
Basic Solution: increase RO deployment.
-
Acetar: launched in October 2020.
-
Ampoule: waiting for the Distribution
Permit Number (NIE).
|
|
 |
|
|
Ampoules |
Acetar-MJB |
|
|
Divisi baru :
Consumer Goods
-
Hand Sanitizer : NIE sudah
siap.
-
Susu Hi Nutrisi : NIE sudah
siap.
-
Vit C 50 mg : NIE sudah siap.
-
Nasal drop : dalam proses registrasi NIE.
-
Mouthwash : dalam proses registrasi NIE.
|
New division:
Consumer Goods
-
Hand Sanitizer: NIE ready.
-
Hi Nutrition Milk:
NIE ready.
-
Vit
C 50 mg: NIE ready.
-
Nasal drop: in the process of NIE
registration.
-
Mouthwash: in the process of NIE
registration.
|
|
 |
|
 |
 |
|
High Protein Milk Powder |
 |
|
 |
 |
|
Vitamin C 50 mg |
Hand Sanitizers |
|
 |
 |
|
Mouthwash |
Nasal Drop |
